湖北均瑶大健康饮品股份有限公司 二〇二四年年度股东大会会议资料 湖北均瑶大健康饮品股份有限公司 二〇二四年年度股东大会 会议资料 湖北均瑶大健康饮品股份有限公司 二〇二四年年度股东大会会议资料 目 录 | 会议须知 | | 3 | | --- | --- | --- | | 会议议程 | | 5 | | 议案一：关于 2024 年度董事会工作报告的议案 7 | | | | 议案二：关于 2024 年度监事会工作报告的议案 8 | | | | 议案三：关于 2024 年度财务决算报告的议案 9 | | | | 议案四：关于 年度利润分配预案的议案 10 | 2024 | | | 议案五：关于公司 2024 年年度报告及摘要的议案 11 | | | | 议案六：关于确认公司董事及监事 2024 年度薪酬的议案 12 | | | | 议案七：关于预计公司 2025 年日常关联交易的议案 13 | | | | 议案八：关于使用部分闲置自有资金进行现金管理暨关联交易的议案 14 | | | | 议案九：关于使用部分自有资金开展金融服务业务暨关联交易的议案 15 | | | 2 湖北均瑶大健康饮品股份有限公司 二〇二四年 ...

出品：新浪财经上市公司研究院 作者：浪头饮食/ 郝显 2024年，乳制品行业加速下行！ 去年A股19家乳制品行业公司总共实现营业收入1848.27亿元，同比减少7.44%。14家乳制品公司营业收 入出现下滑，而前一年仅为6家。归母净利润总额则从130.97亿元下滑到95.76亿元，净利润下滑的公司 达到13家。 "供给过剩、需求走弱、库存偏高"，是压制乳制品行业的三大因素，这导致生鲜乳价格不断下行，行业 竞争变激烈。 这一轮原奶价格下行从2021年开始，目前已经下行三年。从乳业指数来看，从2021年1月高点到2024年9 月低点，已经跌超50%。而从2024年9月起，乳业指数出现一轮明显上涨，市场期待上游去化带动原奶 价格见底，同时促生育等政策带动需求回升。 乳制品行业的拐点会出现吗？ 上市乳企销售费用率整体提升 贝因美销售费用率最高 去年19家上市乳制品企业销售费用总额315.49亿元，同比减少2.96%，低于收入降幅。11家公司销售费 用在减少，其中品渥食品降低了51%，西部牧业降低了20%，皇氏集团（维权）降低了15.68%，熊猫乳 品降低了11.16%，这四家公司营业收入同样也在大幅下滑。 值得一提的 ...

Group 1: Lactobacillus Business Trends - The company positions its lactobacillus business within the broader health beverage framework, moving beyond a single category focus [1] - The lactobacillus beverage segment has seen a decline due to insufficient innovation compared to the overall beverage industry [1] - Sales performance for the lactobacillus business is expected to show slight growth in 2024, driven by increased orders during the Spring Festival, but will be impacted by the absence of this effect in Q1 2025 [1] Group 2: International Expansion and Probiotics Business - The company's overseas operations have shown strong performance, with a 77% year-on-year increase in overseas revenue in Q1 2025 [2] - Significant growth in orders from major U.S. clients reflects the company's long-term strategy of nurturing relationships through technical communication [2] - The company avoids competing in the low-end domestic market, focusing instead on establishing long-term technical collaborations with professional clients [2] Group 3: E-commerce and Brand Performance - The "Daily Doctor" brand has achieved profitability through precise product positioning and market strategy in the functional probiotics segment [3] - The company minimizes reliance on influencer marketing, using it as a supplementary method rather than a core revenue source [3] - The shift towards activating owned brand traffic indicates a growing consumer recognition and repurchase intention for "Daily Doctor" [3]

Group 1: Plant-Based Beverage Industry - The plant-based beverage industry is experiencing a divergence in performance among major companies, with some like Yangyuan Beverage seeing profit growth despite a slight revenue decline, while others like Huanlejia face declines in both revenue and profit [2] - Traditional plant-based beverages are limited by seasonal demand and face competition from emerging categories, necessitating innovation to meet the health-conscious preferences of younger consumers [2] Group 2: Chinese Condiment Industry - The Chinese condiment industry has evolved from a focus on export during the planned economy era to becoming a global rule-maker, with companies like Haitian Flavoring and Lee Kum Kee leading the way [3][4] - The industry is leveraging cultural exports and technological innovation to reshape its landscape, emphasizing quality and innovation to support the globalization of Chinese flavors [4] Group 3: Community Supermarkets - Community supermarkets are gaining traction, with brands like Ole' and Hema NB expanding rapidly, focusing on middle-class consumers and enhancing product quality and efficiency [5] - The core competitiveness of community supermarkets lies in product control and operational efficiency, requiring deep supply chain engagement and digital tool application [5] Group 4: Health and Wellness Trends - There is a growing trend among young consumers towards "light wellness" products, with a focus on health-conscious beverages that are low in sugar and calories [6] - Boxed water products have seen significant sales growth, with products like fig and flaxseed water experiencing a 130% increase in sales [6] Group 5: Instant Food Market - The instant food market is shifting from high-end products to a focus on affordability, with budget products now accounting for nearly 50% of the instant noodle market [7] - Future opportunities lie in diversifying flavors and adjusting strategies to meet the differentiated demands of various market segments [7] Group 6: Aging Population and Bakery Market - The aging population is driving demand for soft-textured baked goods, with health-oriented and age-appropriate products becoming market hotspots [9] - Innovations inspired by Japanese practices, such as low-sugar and low-salt options, are key directions for the industry [9] Group 7: Snack Food Market Forecast - The Chinese snack food market is projected to grow to 972 billion yuan by 2025, with nut snacks holding the largest market share [10] - The industry is witnessing a shift towards health-oriented ready-to-eat products, with e-commerce and live streaming becoming significant growth drivers [10] Group 8: Beverage Market Dynamics - The beverage market is undergoing adjustments, with significant growth in electrolyte water and tea beverages, while packaged water sales are declining [12] - Companies like Nongfu Spring and Eastroc Beverage are experiencing contrasting performance, highlighting the competitive landscape [12] Group 9: Pre-made Dishes Market - The pre-made dishes market is experiencing a cooling phase, with many leading companies facing revenue declines due to changing consumer demands and increased competition [14] - Opportunities remain in local specialties and high-end products, with new retail channels emerging as growth points [14] Group 10: Health Drink Innovations - The market for Chinese herbal health drinks is expanding rapidly, with sales increasing from 0.1 billion yuan in 2018 to an expected 10 billion yuan by 2028 [19] - Companies are focusing on packaging, formulation, and marketing to differentiate themselves in a competitive landscape [19] Group 11: Functional Beverage Market - The functional beverage market is becoming increasingly diverse, with brands like Zhenguanzhuang entering the market with zero-sugar options targeting health-conscious consumers [32] - The collaboration between Zhenguanzhuang and Super Extreme Drink aims to fill market gaps and cater to the preferences of the younger generation [32] Group 12: Snack Food IPO Trends - Recent trends show a surge in snack food companies seeking IPOs in Hong Kong, with brands like Three Squirrels aiming to solidify their market position [21] - These companies face challenges related to competition and growth bottlenecks, despite their ambitions for expansion [21]

湖北均瑶大健康饮品股份有限公司 关于独立董事任期届满辞任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605388 证券简称：均瑶健康 公告编号：2025-024 特此公告。 湖北均瑶大健康饮品股份有限公司董事会 1 2025 年 5 月 10 日 2 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）董事会近日收到独 立董事史占中先生的书面辞呈。根据《上市公司独立董事管理办法》《上海证券 交易所上市公司自律监管指引第 1 号——规范运作》有关规定，独立董事在上市 公司连续任职时间不得超过六年。史占中先生因在公司连续担任独立董事期限已 满六年，现申请辞去公司独立董事、薪酬与考核委员会主任委员、提名委员会委 员的职务，辞任生效后将不在公司担任任何职务。 史占中先生的辞任将导致公司独立董事人数占董事会成员的比例低于三分 之一，根据《上市公司独立董事管理办法》等相关规定，其辞呈将自公司股东大 会选举产生新任独立董事之日起生效。在此之前，为保证公司董事会的正常运作， 将按照相关法律法规及《公司章程》规定继续履职。公 ...

| 主要会计数据 | 2024年 | 2023年 | 本期比 上年同 期增减 | 2022年 | | --- | --- | --- | --- | --- | | | | | (%) | | | 营业收入 | 1. 458. 166. 483. 96 | 1.634. 102. 031. 54 | -10. 77 | 986. 104. 247. 74 | | 扣除与主营业务无关 | 1, 453, 082, 557. 29 | 1, 630, 319, 153. 68 | -10. 87 | 946. 346. 095. 99 | | 的业务收入和不具备 | | | | | | 商业实质的收入后的 | | | | | | 营业收入 | | | | | | 归属于上市公司股东 | -29, 116, 350. 88 | 57.575.881.73 | -150. 57 | 76.735.843.53 | | 的净利润 | | | | | | 归属于上市公司股东 | | | | | | 的扣除非经常性损益 | -57, 997, 852. 48 | 30.911.980. 31 | -287.62 | 49. ...

Core Viewpoint - Junyao Health, known as the "first stock of room temperature lactic acid bacteria" in China, reported a revenue of 401 million yuan for Q1 2025, reflecting a year-on-year growth of 1.41%, while net profit decreased by 58.29% to 10.91 million yuan [1] Financial Performance - Q1 2025 revenue reached 401 million yuan, a 1.41% increase year-on-year [1] - Net profit for Q1 2025 was 10.91 million yuan, down 58.29% compared to the previous year [1] - In 2024, total revenue was reported at 1.458 billion yuan, with the probiotic beverage and food segment contributing 792 million yuan [1] Business Segments - The probiotic food segment saw a significant revenue increase of 139.19% year-on-year in Q1 2025 [1] - E-commerce channel revenue surged by 1173.33% year-on-year [1] - The company is expanding its product matrix and establishing an integrated ecological chain model in the downstream segment [1] Market Trends - The global probiotic industry is expected to exceed 77 billion USD by 2025, with China accounting for over 25% of the market [1] - Junyao Health is positioned to benefit from national policies promoting health consumption upgrades and the "Weight Management Year" initiative [1] International Business - In 2024, the company's international market revenue was approximately 84.6 million yuan, marking a year-on-year growth of 24.54% [1] - Q1 2025 overseas market revenue increased dramatically by 77.43% year-on-year [1] - Junyao Runying, a subsidiary, is one of Asia's largest probiotic production bases, exporting products to over 80 countries and regions [1]

Core Viewpoint - Junyao Health has reported significant growth in its probiotic beverage and food business, positioning itself as a leader in the health industry with a focus on innovation and international expansion [1][2][6] Financial Performance - In 2024, Junyao Health achieved a revenue of 1.458 billion yuan, while the first quarter of 2025 saw revenue of 401 million yuan [1] - The probiotic beverage and food segment generated a total revenue of 792 million yuan in 2024, with a remarkable year-on-year growth of 139.19% in the first quarter of 2025 [2] Market Trends - The probiotic market in China is rapidly expanding, with a compound annual growth rate of 14% from 2018 to 2022, growing from 64.77 billion yuan to approximately 109.38 billion yuan [2] - Global probiotic industry value is expected to exceed 77 billion USD by 2025, with China accounting for over 25% of the market share [2] R&D and Innovation - Junyao Health emphasizes the importance of independent research and development, establishing a comprehensive "R&D-production-sales" integrated chain [2][3] - The subsidiary Junyao Runying has developed a resource library of over 30,000 probiotic strains and collaborates with several universities to enhance innovation [3] Supply Chain and Distribution - The company has expanded its e-commerce channels, achieving a staggering 1173.33% year-on-year growth in online sales in the first quarter of 2025 [2] - Junyao Health has established a comprehensive supply chain model, integrating raw materials, products, and distribution channels [3][4] International Expansion - In 2024, Junyao Health's international business generated approximately 84.6 million yuan, reflecting a year-on-year growth of 24.54%, with a 77.43% increase in the first quarter of 2025 [5] - Junyao Runying is recognized as a major probiotic production base in Asia, exporting to over 80 countries and regions [5] Policy and Market Outlook - The national initiative to promote "Weight Management Year" is expected to further boost the health industry, providing a favorable environment for Junyao Health's growth [6] - With its leading position in the ambient yogurt market and a comprehensive probiotic strategy, Junyao Health is well-positioned for sustained growth in the health industry [6]

Core Viewpoint - The Chinese government is promoting a "Weight Management Year" initiative, which is expected to significantly boost the health industry, potentially exceeding a trillion yuan in market size. This creates a favorable environment for companies like Junyao Health, which is focusing on expanding its leadership in the probiotic market and enhancing its product offerings [1][2]. Group 1: Company Performance - Junyao Health reported revenues of approximately 1.458 billion yuan for 2024 and 401 million yuan for the first quarter of 2025, with a notable 139.19% increase in probiotic food revenue in Q1 2025 [1][3][4]. - The company achieved a gross margin of 38.39% in 2024, an increase of 1.98% from the previous year, attributed to reduced raw material costs and optimized operational management [3][4]. Group 2: Market Trends - The health industry in China is projected to reach a market size of 13.4 trillion yuan by 2025 and further grow to 29.1 trillion yuan by 2030, driven by the "Healthy China 2030" strategy [2]. - The probiotic market in China has seen significant growth, with a compound annual growth rate of 14% from 2018 to 2022, increasing from 64.77 billion yuan to approximately 109.38 billion yuan [5]. Group 3: Product Development - Junyao Health is expanding its product line to include low-temperature active probiotic beverages, leveraging innovative fermentation technology and developing functional beverages that combine probiotics with other beneficial ingredients [2][4]. - The company has developed a diverse range of health functional beverages, including products targeting beauty, eye health, sleep, and nutrition, to meet various consumer health needs [2][4]. Group 4: Strategic Initiatives - Junyao Health is enhancing its research and development capabilities by integrating with leading companies in the probiotic sector, establishing a comprehensive "R&D-production-sales" integrated system to strengthen its market position [6][7]. - The company is expanding its e-commerce presence, with a significant increase in online sales, particularly in the first quarter of 2025, where e-commerce revenue surged by 1,173.33% [4][8]. Group 5: International Expansion - Junyao Health's international business achieved revenue of approximately 84.6 million yuan in 2024, a year-on-year increase of 24.54%, with Q1 2025 showing a remarkable growth of 77.43% [9]. - The company exports to over 80 countries and regions, positioning itself as a leading exporter of probiotics in China, benefiting from competitive pricing and stable supply chains [9]. Group 6: Future Outlook - With the release of production capacity, strengthened technological barriers, and expanded brand influence, Junyao Health is expected to continue leading the health industry and achieve long-term stable growth [10].

湖北均瑶大健康饮品股份有限公司 内部控制审计报告 众环审字（2025）2300488号 目 起始页码 1 内部控制审计报告 众环审字(2025) 2300488 号 湖北均瑶大健康饮品股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计了湖 北均瑶大健康饮品股份有限公司（以下简称"均瑶健康公司"）2024 年 12 月 31 日的财务报 告内部控制的有效性。 一、均瑶健康公司对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指引》 的规定,建立健全和有效实施内部控制,并评价其有效性是均瑶健康公司董事会的责任。 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://xec.mof.gov.cn）" 近行 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）" 近行 ： 内部控制审计报告 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计意见, 并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、 内部控制的固有局限 ...